

Fundamental dimension Equity attribute | FRPTLeader $64.12▼-4.30% Cap $3.15BP/E 15.4x QuantScore64/100 | BARKPeer $7.68▼-0.90% Cap $69.38MP/E -2.1x QuantScore44/100 | CENTPeer $45.38▲+0.55% Cap $2.52BP/E 16.8x QuantScore61/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
82/100 |
46/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 73/100 | 33/100 | 96/100 |
Health Piotroski, Altman Z, leverage & liquidity | 78/100 | 37/100 | 56/100 |
Growth Revenue / earnings growth & margins | 58/100 | 17/100 | 26/100 |
Sentiment Analyst ratings, targets & revisions | 27/100 | 88/100 | 54/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 15.4x | -2.1x | 16.8x |
Forward P/E (next FY) | 32.3x | -5.6x | 15.3x |
EV / EBITDA (TTM) | 13.0x | -4.1x | 8.4x |
Price / Sales | 2.7x | 0.2x | 0.8x |
Price / Free Cash Flow | 18.7x | -2.9x | 7.3x |
PEG ratio | 0.03 | 0.13 | 0.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 4 / 9 | 7 / 9 |
Altman Z-Score | 4.45 (Safe) | -0.97 (Distress) | 2.71 (Grey) |
Total debt / equity | 0.40 | 0.48 | 0.81 |
Quick ratio | 5.0x | 0.8x | 2.7x |
Interest coverage | 15.3x | -27.6x | 4.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +13.0% | -18.5% | -2.2% |
Net income growth YoY | +196.5% | -18.6% | +50.8% |
Gross margin (TTM) | 39.3% | 63.4% | 32.5% |
Operating margin (FY) | 8.6% | -10.2% | 8.5% |
FCF margin (FY) | 1.1% | -6.7% | 9.3% |
5. Trailing price performancePrice change over period |
1M return | +10.0% | -5.2% | +14.9% |
3M return | +11.4% | -9.8% | +3.7% |
6M return | -3.1% | -19.7% | +17.9% |
Year to date | +5.2% | -36.3% | +41.2% |
1Y return | +18.5% | -55.5% | +41.8% |
3Y return | +10.3% | -63.1% | +33.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-14.06 -121.9% premium | $-33.03 -530.1% premium | $55.91 +23.2% upside |
Wall Street consensus target | $70.40 +9.8% · range $66.00–$75.00 | $15.50 +101.8% · range $12.00–$19.00 | $54.00 +19.0% · range $54.00–$54.00 |
Consensus stance | 55% Buy41% Hold3% Sell | 75% Buy25% Hold0% Sell | 60% Buy40% Hold0% Sell |